Stem cell treatment halts MS for some patients medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
aHSCT Beneficial for Most Patients With Relapsing-Remitting MS omaha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from omaha.com Daily Mail and Mail on Sunday newspapers.
TUESDAY, Sept. 26, 2023 (HealthDay News) Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most patients, according to